Advirna LLC is a small biotechnology company, founded in 2006 by Alexey Wolfson, Ph.D. and Anastasia Khvorova, Ph.D., RXi’s Chief Scientific Officer, located in Boulder, CO. The company is primarily focused on the discovery and development of next generation nucleotide chemistries and formulation to enable efficient and non-toxic oligonucleotide delivery to a range of tissues.